![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Tag: Coronavirus information (COVID-19)
Press Releases
Altimmune Adds Lonza as a Manufacturing Partner for Supply of AdCOVID its Single-Dose Intranasal Vaccine Candidate for COVID-19
Altimmune, Inc., a clinical-stage biopharmaceutical company, announced that it entered into an agreement with Lonza for the manufacturing of AdCOVID™, Altimmune’s next-generation, single-dose intranasal...
Press Releases
Lilly’s neutralizing antibody bamlanivimab receives FDA emergency use authorization for the treatment of recently diagnosed COVID-19
The U.S. FDA granted Emergency Use Authorization for Eli Lilly and Company's investigational neutralizing antibody bamlanivimab 700 mg. Bamlanivimab is authorized for the treatment...
News
Australia begins production of Oxford Covid-19 vaccine, plans to manufacture 30 million doses
A Covid-19 vaccine co-developed by pharmaceutical company AstraZeneca and the University of Oxford is seen as one of the most promising of all the...
News
Brazil Suspends Trials Of Chinese Covid-19 Vaccine Due To Adverse Incident
Brazil’s health regulator halted clinical trials of the potential coronavirus vaccine CoronaVac, citing an adverse, serious event, according to a statement it posted to...
Clinical Trials
Cancer Treatment Can Be Cloned For COVID-19
As per the recent international study by the scientists from Italy & Australia, Beta-blockers have it in them to be a potential treatment for...
News
Novavax COVID-19 Vaccine Granted Fast Track Designation by U.S. FDA
Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced that the U.S. FDA has granted Fast Track Designation for...
News
Llama nanobodies could be a powerful weapon against COVID-19
The researchers at the University of Pittsburgh School of Medicine describe a new method to extract tiny but extremely powerful SARS-CoV-2 antibody fragments from...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read